CollPlant Reports Final Trial Results for VergenixSTR in the Treatment of Tendinopathy

CollPlant announced positive final clinical trial results for Vergenix™STR, intended for the treatment of tendinopathy. The company submitted its technical file in late 4Q15 in anticipation of CE Mark approval in 2Q16.

The objective of the Company's prospective, open label, single arm trial was to demonstrate safety and performance of...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us